US Patent Issued to Atai Therapeutics on Aug. 5 for "N, n-dimethyltryptamine salts and crystalline salt forms" (Canadian, American, German Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,194, issued on Aug. 5, was assigned to Atai Therapeutics Inc. (New York).

"N, n-dimethyltryptamine salts and crystalline salt forms" was invented by Majed Fawaz (Foxborough, Mass.), Nicholas Morra (Ontario, Canada) and Setu Kasera (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "A N,N-dimethyltryptamine (DMT) succinate crystalline form."

The patent was filed on May 25, 2022, under Application No. 17/824,861.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12378194&OS=12378194&...